Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 5 min ago
Peer-reviewedCC BY-NC-ND 4.0BMC Public Health

COVID-19 and subsequent new allergy drug prescriptions: a matched cohort study in Japan

Related

  1. Maternal opioid prescriptions and subsequent risk of hospital admission in offspring in South Korea: A nationwide birth cohort study
    Hyeon Jin Kim, Yesol Yim, Christa J. Nehs +7
    PLOS MedicinePeer-reviewedCC BYFull textPharmacology & toxicologyObstetrics, gynaecology & paediatricsPLOSEurope PMC
  2. COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study
    Jérôme Doyen, Alexandre Lacour, Renaud Schiappa +4
    JNCI Cancer SpectrumPeer-reviewedCC BY 4.0Full textOncologyPMC
  3. Takayasu Arteritis in a Middle-aged Woman Following Prolonged Subsequent Fever after COVID-19 Infection: An Early Diagnosis Using Contrast-enhanced CT
    Masayo Watanabe, Takuya Tanimoto, Mari Tanaka +6
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  4. Commentary: Cat exposure and asthma outcomes in a cohort of children with asthma and allergy
    Milad Ameri, Pål Johansen, Marie-Charlotte Brüggen
    Frontiers in AllergyPeer-reviewedCC BY 4.0Full textPhysiologyPMC
  5. Prospective birth cohort: Cephalosporins drive gut microbiota and food allergy☆
    Ning Zhu, Yimin Zhao, Fangyuan Cai +6
    The World Allergy Organization journalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{miyamori2026covid19,
  title = {{COVID-19 and subsequent new allergy drug prescriptions: a matched cohort study in Japan}},
  author = {Daisuke Miyamori and Shuhei Yoshida and Masanori Ito},
  journal = {BMC Public Health},
  year = {2026},
  month = oct,
  doi = {10.1186/s12889-026-29757-0},
  url = {https://link.springer.com/article/10.1186/s12889-026-29757-0},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - COVID-19 and subsequent new allergy drug prescriptions: a matched cohort study in Japan
AU  - Daisuke Miyamori
AU  - Shuhei Yoshida
AU  - Masanori Ito
PY  - 2026
DA  - 2026/10/14
JO  - BMC Public Health
DO  - 10.1186/s12889-026-29757-0
UR  - https://link.springer.com/article/10.1186/s12889-026-29757-0
SN  - 1471-2458
ER  -